Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.28 USD | +3.46% | +0.64% | -8.92% |
03-13 | Roth MKM Adjusts Price Target on Clarus to $7.50 From $6.50, Maintains Buy Rating | MT |
03-11 | Transcript : Clarus Corporation - Analyst/Investor Day |
Sales 2024 * | 276M 22.07B | Sales 2025 * | 310M 24.83B | Capitalization | 240M 19.22B |
---|---|---|---|---|---|
Net income 2024 * | -4M -320M | Net income 2025 * | - 0 | EV / Sales 2024 * | 0.6 x |
Net cash position 2024 * | 75.73M 6.06B | Net cash position 2025 * | 82.8M 6.63B | EV / Sales 2025 * | 0.51 x |
P/E ratio 2024 * |
-50.2
x | P/E ratio 2025 * |
-942
x | Employees | 500 |
Yield 2024 * |
1.59% | Yield 2025 * |
1.59% | Free-Float | 67.94% |
Latest transcript on Clarus Corporation
1 day | +3.46% | ||
1 week | +0.64% | ||
Current month | -6.96% | ||
1 month | -6.41% | ||
3 months | +1.45% | ||
6 months | +9.41% | ||
Current year | -8.92% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Yates
DFI | Director of Finance/CFO | 58 | 02/01/22 |
Donald House
BRD | Director/Board Member | 82 | 31/12/92 |
Members of the board | Title | Age | Since |
---|---|---|---|
Warren Kanders
CHM | Chairman | 66 | 31/05/02 |
Nicholas Sokolow
BRD | Director/Board Member | 74 | 31/05/02 |
Donald House
BRD | Director/Board Member | 82 | 31/12/92 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - | |
0.00% | 147 M€ | +4.88% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.28 | +3.46% | 102,373 |
25/04/24 | 6.07 | -3.65% | 141,437 |
24/04/24 | 6.3 | +2.44% | 112,753 |
23/04/24 | 6.15 | +1.32% | 99,709 |
22/04/24 | 6.07 | -2.72% | 114,333 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.92% | 240M | |
+4.27% | 5.09B | |
+5.73% | 4.04B | |
-1.49% | 3.94B | |
+10.53% | 2.92B | |
-1.16% | 1.9B | |
+92.11% | 1.23B | |
-4.80% | 838M | |
-9.30% | 853M | |
+2.24% | 809M |
- Stock Market
- Equities
- CLAR Stock